174
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Liposomes formulated with fMLP-modified cholesterol for enhancing drug concentration at inflammatory sites

, , , , , , , , & show all
Pages 165-174 | Received 14 Mar 2013, Accepted 01 Oct 2013, Published online: 06 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tarun Garg, Saurav Bhandari, Goutam Rath & Amit K. Goyal. (2015) Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor. Journal of Drug Targeting 23:10, pages 865-887.
Read now

Articles from other publishers (6)

Anirudh Gairola, Aaron Benjamin, Joshua D. Weatherston, Jeffrey D. Cirillo & Hung‐Jen Wu. (2022) Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages. Advanced Therapeutics 5:6.
Crossref
Manish Kumar, Abhishek Jha, Kanchan Bharti, Gourav Parmar & Brahmeshwar Mishra. (2022) Advances in lipid-based pulmonary nanomedicine for the management of inflammatory lung disorders. Nanomedicine 17:12, pages 913-934.
Crossref
Zsuzsa Baranyai, Héctor Soria‐Carrera, Maria Alleva, Ana C. Millán‐Placer, Ainhoa Lucía, Rafael Martín‐Rapún, José A. Aínsa & Jesús M. la Fuente. (2020) Nanotechnology‐Based Targeted Drug Delivery: An Emerging Tool to Overcome Tuberculosis. Advanced Therapeutics 4:1, pages 2000113.
Crossref
Daniel Yuan Qiang WongDaniel Yuan Qiang Wong. 2018. Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno-chemotherapeutic Approaches. Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno-chemotherapeutic Approaches 103 130 .
Daniel Yuan Qiang Wong, Charmian Hui Fang Yeo & Wee Han Ang. (2014) Immuno‐Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents. Angewandte Chemie International Edition 53:26, pages 6752-6756.
Crossref
Daniel Yuan Qiang Wong, Charmian Hui Fang Yeo & Wee Han Ang. (2014) Immuno‐Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents. Angewandte Chemie 126:26, pages 6870-6874.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.